Aerie Pharmaceuticals reported $40.41M in Stock for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Alimera Sciences ALIM:US $ 2.45M 0.23M
Amarin AMRN:US $ 267.82M 33.14M
Cara Therapeutics CARA:US 1.91M 677K
Endo International Ordinary Shares ENDP:US $ 283.83M 0.27M
JAZZ PHA JAZZ:US $ 985.45M 87.27M
Merk MRK:US $ 5774M 179M
Novartis NOVN:VX SF 6997M 331M
Pacira Pharmaceuticals PCRX:US $ 103.66M 5.11M
Regeneron Pharmaceuticals REGN:US $ 1991.5M 488.7M
Revance Therapeutics RVNC:US $ 10.66M 0.5M
Supernus Pharmaceuticals SUPN:US $ 88.8M 2.84M
Teva Pharmaceutical Industries TEVA:US $ 4012M 194M
Valeant Pharmaceuticals VRX:CN $ 1045M 52M
Zoetis ZTS:US $ 2057M 134M